The Australian Centre for Hepatitis Virology (ACHV) is an incorporated body of biomedical scientists throughout Australia with the common interest of promoting and disseminating research into all aspects of the hepatitis and related viruses.
ACHV Workshops
29 November - 2 December 2023
The 18th ACH4 annual scientific workshop was held in conjunction […]
25-27th May 2022
The 17th ACH2 annual scientific workshop was held at the […]
2 - 4 June 2021
The 16th ACH2 annual scientific workshop was held at Peppers […]
Tweets
This study finds B-cell traits, not broad antibodies, are key in HCV reinfection outcomes! This insight could shape targeted vaccine strategies. #HCV #vaccine
WHO's 2030 targets to eliminate HIV & HCV need fast, real-time viral surveillance. This review covers next-gen sequencing (NGS) methods like genome amplification & tiling PCR to track outbreaks & guide targeted interventions. #NGS #PublicHealth #HCV https://onlinelibrary.wiley.com/doi/epdf/10.1002/rmv.70001
High levels of hepatitis B core-related antigen (HBcrAg) at the end of treatment predict a higher risk of hepatitis flare after stopping therapy. Monitoring HBcrAg could be key in guiding treatment decisions for chronic hep B. #LiverHealth #HepatitisB
At CGHE, we're celebrating #WorldHepatitisDay with our partners throughout July!
Visit https://buff.ly/4cJHIMm to explore ways you can participate in this year's activities, like downloading the CGHE World Hepatitis Day 2024 Zoom Background.